No phaseRecruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Sponsor
Duke University (Academic or other)
Enrolment
500 planned
Conditions
Chronic Kidney Disease(CKD); Type 2 DM; Type 2 Diabetes Mellitus (T2DM)
Interventions
(IRIS-CKD Screening Program): Home Kit; (IRIS-CKD Screening Program): Standard Lab Order
Ages
adults, older adults
Registry
NCT06906627

From the registry

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

Primary outcomes

  • CKD Screening Lab Opportunity Score
Full record on ClinicalTrials.gov